Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for A Quarter century of Multiple Myeloma Mortality: Evolving Trends in Older Americans from a Nationwide CDC WONDER Analysis

MM - 1347

A Quarter century of Multiple Myeloma Mortality: Evolving Trends in Older Americans from a Nationwide CDC WONDER Analysis

Moazzam Hussain

Poster Presenter: Moazzam Hussain

Thumbnail for GLP-1 Receptor Agonists and Organ Function Outcomes in Amyloid Light-Chain Amyloidosis: A Real-World Analysis From the TriNetX Global Collaborative Network

MM - 1350

GLP-1 Receptor Agonists and Organ Function Outcomes in Amyloid Light-Chain Amyloidosis: A Real-World Analysis From the TriNetX Global Collaborative Network

Dhriti Sood

Poster Presenter: Dhriti Sood

Previous 1...105 106 107 108 109 110 111...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

$Thumbnail for Comparative Real-World Outcomes of CAR T-Cell Therapy vs Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Propensity-Matched TriNetX Analysis$

MM - 1370

Comparative Real-World Outcomes of CAR T-Cell Therapy vs Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Propensity-Matched TriNetX Analysis

Rukash Khan Niazi

Poster Presenter: Rukash Khan Niazi

Thumbnail for Comparative Effectiveness and Safety of Talquetamab Versus Teclistamab in Multiple Myeloma: A Real-World Propensity-Matched Study

MM - 1377

Comparative Effectiveness and Safety of Talquetamab Versus Teclistamab in Multiple Myeloma: A Real-World Propensity-Matched Study

Rukash Khan Niazi

Poster Presenter: Rukash Khan Niazi

$Thumbnail for Real-World Infection Risk Associated With Teclistamab in Relapsed/Refractory Multiple Myeloma$

MM - 1396

Real-World Infection Risk Associated With Teclistamab in Relapsed/Refractory Multiple Myeloma

Nour Sabiha Naji

Poster Presenter: Nour Sabiha Naji

Thumbnail for Disseminated Intravascular Coagulation in Multiple Myeloma: A Nationwide Analysis of Mortality, Organ Failure, and Healthcare Utilization

MM - 1400

Disseminated Intravascular Coagulation in Multiple Myeloma: A Nationwide Analysis of Mortality, Organ Failure, and Healthcare Utilization

Farheen Malik

Poster Presenter: Farheen Malik

Thumbnail for Pneumonia-Related Mortality in Multiple Myeloma: A Joinpoint Regression Analysis of US Mortality Trends (1999-2020)

MM - 1405

Pneumonia-Related Mortality in Multiple Myeloma: A Joinpoint Regression Analysis of US Mortality Trends (1999-2020)

FNU Sagar

Poster Presenter: FNU Sagar

$Thumbnail for Efficacy of Venetoclax-Based Therapy in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis$

MM - 1409

Efficacy of Venetoclax-Based Therapy in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Vasu Malhotra

Poster Presenter: Vasu Malhotra

$Thumbnail for Bispecific Antibodies Versus CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Comparative Meta-Analysis of Efficacy and Safety$

MM - 1415

Bispecific Antibodies Versus CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Comparative Meta-Analysis of Efficacy and Safety

Dua Azim

Poster Presenter: Dua Azim

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors